Anish R. Maskey - Immunology and Microbiology - Best Researcher Award
New York Medical College - United States
Author Profile
ORCID
Short Biography
Dr. Anish R. Maskey is a dedicated postdoctoral fellow in the Department of Pathology, Microbiology, and Immunology at New York Medical College. With a strong foundation in allergy, immunology, and infectious disease, Dr. Maskey specializes in translational research, focusing on biomarker discovery and novel therapies for chronic inflammatory and allergic diseases. His approach combines immunological assays, in vitro modeling, and in vivo murine studies to uncover therapeutic mechanisms and assess drug efficacy. Over six years of research, he has cultivated a robust understanding of B and T cell immunology, immuno-oncology, and host-pathogen interactions. Known for his collaborative spirit and leadership skills, Dr. Maskey is also passionate about mentoring emerging scientists and fostering interdisciplinary teamwork. He actively contributes to international symposia, peer-reviewed publications, and editorial boards. His ongoing research explores innovative therapeutic strategies using natural products, aiming to translate laboratory findings into clinical solutions for complex immune-related conditions.
Education
Dr. Anish R. Maskey earned his Ph.D. in Pathology, Microbiology, and Immunology in 2023 from New York Medical College with a CGPA of 3.75/4.0. His doctoral research explored molecular mechanisms and drug discovery for eosinophilic esophagitis and allergic inflammation. Before moving to the United States, he completed his undergraduate studies in Medical Laboratory Technology at the Institute of Medicine, Kathmandu, Nepal, in 2016, graduating with distinction. His academic journey is marked by an exceptional blend of clinical acumen and research excellence. Dr. Maskey has consistently demonstrated a commitment to applying biomedical knowledge to solve immunological disorders, which guided his transition from clinical training to experimental research. His advanced coursework in immunology and pathology laid the groundwork for his specialization in immune modulation and therapeutic innovation. Through formal academic roles and teaching appointments, he has furthered his education by staying engaged with the latest scientific advancements and pedagogical practices.
Professional Experience
Since June 2023, Dr. Maskey has served as a postdoctoral fellow at New York Medical College, where he is deeply involved in multiple translational research projects. These include clinical biomarker studies, investigations into eczema therapy, and murine models of skin infection and food allergies. He is a Co-Investigator and Co-Principal Investigator on several IRB- and IACUC-approved studies, evaluating the effects of natural compounds and nanoparticle-based therapeutics. His prior experience as a graduate researcher (2018–2023) involved pioneering therapeutic investigations into eosinophilic esophagitis and peanut-induced anaphylaxis. Alongside his research roles, he has participated extensively in teaching at the graduate and medical levels, delivering lectures in microbiology and immunology. He has mentored over 25 trainees, including visiting scientists and residents, and coordinated interdisciplinary collaborations across the U.S., India, and China. With a strong background in laboratory management and clinical protocol development, he effectively bridges experimental and clinical domains to advance immune-based therapies.
Research Interests
Dr. Maskey’s research interests span immunoregulation, allergic inflammation, host-microbiome interaction, and natural compound-based therapeutics. He is particularly intrigued by the immunological mechanisms underlying chronic inflammatory diseases, including food allergies, atopic dermatitis, and eosinophilic esophagitis. A significant focus of his work is identifying predictive biomarkers and validating the efficacy of botanical agents and bioactive compounds. His projects use a multifaceted approach: isolating PBMCs, analyzing nasal polyps, and applying in vivo models to study cytokine profiles and gene expression in allergic responses. He is also investigating how nanoparticle delivery systems can improve drug efficacy and safety in food allergies. Additionally, his work explores the impact of skin microbiota and topical therapies in eczema, with translational potential for pediatric populations. Dr. Maskey is passionate about bridging basic science and clinical practice, seeking therapies that are both innovative and patient-centric. His long-term vision is to develop personalized, natural-product-based interventions for immune disorders.
Awards and Honors
Dr. Anish R. Maskey has received numerous awards that underscore his excellence in research and scientific communication. Notably, he earned the AAAAI PhD Travel Scholarship three years in a row (2023–2025) and was recognized with the Outstanding Abstract Award at the 2024 Touro Research Day. In 2023, he received the APFED Travel Grant and was awarded second place for an oral abstract at the 1st PMI event at New York Medical College. He has also received the ASBMB Graduate/Postdoctoral Travel Award and was a runner-up in the 2022 Science in a Flash competition. Beyond individual accolades, Dr. Maskey has been selected for editorial roles on prestigious journals, including The FASEB Journal and Frontiers in Allergy. These honors reflect not only his scientific rigor but also his ability to communicate and lead within the academic community. His dedication has been recognized across national conferences, institutional research symposia, and professional organizations.
Publication Top Notes
-
Title: Berberine Suppression of Human IgE but Not IgG Production via Inhibition of STAT6 Binding Activity at IgE Promoter by BCL6
Authors: Anish R. Maskey, Michelle Carnazza, Madison Spears, Steven Hemmindinger, Daniel Kopulos, Nan Yang, Humayun K. Islam, Augustine L. Moscatello, Jan Geliebter, Raj K. Tiwari et al.
Journal: Cells (Published: 2025-04-14)
-
Title: Berberine Inhibits the Inflammatory Response Induced by Staphylococcus aureus Isolated from Atopic Eczema Patients via the TNF-α/Inflammation/RAGE Pathways
Authors: Anish R. Maskey, Daniel Kopulos, Matthew Kwan, Niradiz Reyes, Christian Figueroa, Xian Mo, Nang Yang, Raj Tiwari, Jan Geliebter, Xiu-Min Li
Journal: Cells (Published: 2024-10)
-
Title: Preclinical Models of Atopic Dermatitis Suitable for Mechanistic and Therapeutic Investigations
Authors: Anish Maskey, Xian Mo, Xiu-Min Li
Journal: Journal of Inflammation Research (Published: 2024-10)
-
Title: The Efficacy & Molecular Mechanisms of a Terpenoid Compound Ganoderic Acid C1 on Corticosteroid-Resistant Neutrophilic Airway Inflammation: In vivo and in vitro Validation
Authors: Zhen-Zhen Wang, Hang Li, Anish Maskey, Kamal Srivastava, Changda Liu, Nan Yang, Taoyun Xie, Ziyi Fu, Junxiong Li, Xiaohong Liu et al.
Journal: Journal of Inflammation Research (Published: 2024-04)